Cell Culture High-Rise

A little over a year ago, BioCrystal of Westerville, Ohio, introduced the futuristically designed OptiCell™ for tissue culture.1 The 100-cm2 growth area of each OptiCell (33% more than a T-75 flask) requires only 10 ml of growth medium. Building on this invention, BioCrystal developed a fully automated Robotic Cell Culture System (RC2S) capable of processing 402 OptiCells from inoculation to harvest with almost no human intervention. "Our focus is on growing anchorage-dependent cells," say

Written bySusan Jenkins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tools for bulk cell culture currently include stir-tank ($150,000-$200,000) and cell-cube ($50,000-$100,000) bioreactors, roller bottles, and hollow-fiber systems. "A roller bottle output of 8-10 billion cells (cell-line dependent) would require at least 15 liters of medium, assuming no medium change was necessary," comments Ed McKillip senior research scientist and supervisor of the bioreactor labs in Princeton, NJ, for Radnor, Pa.-based Wyeth. An equivalent output can be achieved with only 10 ml of medium per cassette in the RC2S, thereby using four liters of the most costly reagent needed, or about 25% of a roller bottle run. After reviewing the specifications of the RC2S, McKillip adds that having multiple reagent delivery lines (currently 10) means that researchers can expose a single cell line to many different test compounds, or treat many different cell lines with one reagent.

Unlike conventional cell culture that entails nonsterile trips in and out of the incubator, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies